PSMD7 — patent landscape

Top predicted compounds (top 20 by supporting neighbours, then confidence)

Compound	Confidence	Supporting neighbours
SCHEMBL1478606	0.58	12/20
SCHEMBL607010	0.56	12/20
SCHEMBL608381	0.53	12/20
SCHEMBL606616	0.51	12/20
SCHEMBL1477637	0.57	11/20
SCHEMBL607972	0.55	11/20
SCHEMBL608782	0.54	11/20
SCHEMBL609278	0.54	11/20
SCHEMBL607553	0.54	11/20
SCHEMBL605822	0.54	11/20
SCHEMBL606932	0.53	11/20
SCHEMBL1477893	0.53	11/20
SCHEMBL608362	0.53	11/20
SCHEMBL608599	0.53	11/20
SCHEMBL1327441	0.53	11/20
SCHEMBL605129	0.52	11/20
SCHEMBL608009	0.52	11/20
SCHEMBL1478157	0.52	11/20
SCHEMBL609081	0.52	11/20
SCHEMBL606926	0.52	11/20

Clinical trials — most relevant to PSMD7 by text similarity (a relevance ranking, not an exhaustive list)

Trial	Phase	Status
A Prospective, Placebo Controlled, Double-Blind, Cross-over Study on the Effects of a Probiotic Preparation (VSL#3) on Metabolic Profile, Intestinal Permeability, Microbiota, Cytokines and Chemokines Expression and Other Inflammatory Markers in Pediatric Patients With Crohn's Disease	PHASE4	UNKNOWN
The Effect of Roxadustat on Renal Oxygenation in Diabetes Nephropathy	PHASE2	NOT_YET_RECRUITING
Biologic Correlative Taxotere/AC	PHASE2	COMPLETED
Tamoxifen and Bortezomib to Treat Recurrent Brain Tumors	PHASE2	COMPLETED
Phase II Study of Vandetanib in Individuals With Kidney Cancer	PHASE2	COMPLETED
Desferal Administration to Improve the Impaired Reaction to Hypoxia in Diabetes	PHASE2	UNKNOWN
PS-341 and Radiation to Treat Advanced Cancer of the Head and Neck	PHASE1	COMPLETED
Study of Patients With Stage IV Malignant Melanoma Using PS-341 (Bortezomib, Velcade) and Interferon-alpha-2b in Malignant Melanoma	PHASE1	COMPLETED
Feasibility Study Of Adding Bortezomib to R-ICE Chemotherapy To Treat Relapsed/ Refractory Diffuse Large B-Cell Lymphoma	PHASE1	COMPLETED
Study of Irinotecan and Bortezomib in Children With Recurrent/Refractory Neuroblastoma	PHASE1	COMPLETED
Low Dose Melphalan and Bortezomib for AML and High-Risk MDS	nan	COMPLETED
Autophagy in Systemic Lupus Erythematosus	nan	UNKNOWN
Effect of Diaphragm Stimulation During Surgery	nan	COMPLETED
Effect of Dietary Nitrate on Immobilization-induced Changes in Skeletal Muscle in Young Healthy Men	nan	RECRUITING
The PREServation of MUScle Function in Critically Ill Patients (PRESMUS)	nan	UNKNOWN
Autophagy Bladder Cancer	nan	UNKNOWN
Differential Gene Expression of Liver Tissue and Blood From Individuals With Chronic Viral Hepatitis	nan	UNKNOWN
Clinical Study of 68Ga-DOTA-BLP PET Imaging in Noninvasive Diagnosis of Malignant Tumors	nan	NOT_YET_RECRUITING
Collection of Blood Samples for DNA in Motor Neuron Disease	nan	COMPLETED
Evaluation of Proteasome as a Marker of Hepatocellular Carcinoma in Cirrhotic Patients Following Curative Treatment	nan	UNKNOWN
Cardiovascular Complications of Carfilzomib Treatment	nan	UNKNOWN
Mitochondrial Activity and Myosteatosis in the Cachexia of Cancers of the Upper Aerodigestive Tract	nan	UNKNOWN
Quantitative Assessment of the Etiologies of Megalencephaly Associated With a Detectable Tumor Risk	nan	NOT_YET_RECRUITING
Whole-genome Sequencing Study in Patients With Diminished Ovarian Reserve	nan	UNKNOWN
Impact of O6-methylguanine-DNA Methyltransferase (MGMT) Promoter Methylation and MGMT Expression on Dacarbazine Treated Sarcoma Patients (MGMT)	nan	UNKNOWN
Implementation of Molecular Diagnostic Pathways	nan	UNKNOWN
Signs and Symptoms of Genetic Abnormalities Linked to Inherited Heart Disease	nan	COMPLETED
Inhibition of SENP1 for the Suppression of OS Growth and Metastasis	nan	UNKNOWN
Hereditary Spastic Paraplegia Genomic Sequencing Initiative (HSPseq)	nan	RECRUITING
Exercise Therapy to Reduce Heart Failure Symptoms; Sorting Mechanisms of Benefit	nan	COMPLETED

Related proteins — ESM-2 sequence neighbours (a PSMD7 binder may also engage these)

Protein	Name	Similarity
Q3ZBD0	—	1.000	Q3ZBD0 →
Q8WZY4	—	1.000	Q8WZY4 →
P26516	—	1.000	P26516 →
P26270	—	1.000	P26270 →
Q75F44	—	0.998	Q75F44 →
Q9C774	—	0.995	Q9C774 →
Q6FMD8	—	0.995	Q6FMD8 →
Q54WI8	—	0.994	Q54WI8 →
B3NB67	—	0.993	B3NB67 →
B0X2G0	—	0.993	B0X2G0 →
B4QVL3	—	0.993	B4QVL3 →
Q1HR47	—	0.992	Q1HR47 →
Q54C49	—	0.992	Q54C49 →
B4NJR8	—	0.992	B4NJR8 →
O24412	—	0.991	O24412 →
Q7QD36	—	0.991	Q7QD36 →
B3MP94	—	0.991	B3MP94 →
B4N116	—	0.991	B4N116 →
B4LZ60	—	0.991	B4LZ60 →
B4JGX4	—	0.991	B4JGX4 →
O01974	—	0.990	O01974 →
B4QD77	—	0.990	B4QD77 →
B4P3T9	—	0.990	B4P3T9 →
B4I1C2	—	0.990	B4I1C2 →
Q295I4	—	0.990	Q295I4 →
Q9VN50	—	0.990	Q9VN50 →
B4I3S1	—	0.990	B4I3S1 →
B3M123	—	0.989	B3M123 →
Q6C1I3	—	0.989	Q6C1I3 →
B3MJ61	—	0.988	B3MJ61 →